Gogo (NasdaqGS:GOGO) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsChris Moore - CEOWill Davis - Head of Investor RelationsZachary Cotner - CFOConference Call ParticipantsAlexander Phipps - AnalystJustin Lang - AnalystScott Searle - Managing Director and Senior Research AnalystSebastiano Petti - Senior Research AnalystOperatorGood day, and thank you for standing by. Welcome to Gogo's fourth quarter 2025 earnings conference call. At this time, all participants are in a listen-only m ...

TTEC (NasdaqGS:TTEC) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsBob Belknap - Group VP, Corporate FinanceJonathan Lee - Managing Director, Equity ResearchKenneth R. Wagers III - CFOKenneth Tuchman - Chairman and CEOVincent A. Colicchio - Managing DirectorConference Call ParticipantsGeorge Sutton - Senior Research AnalystMaggie Nolan - Research Analyst, Technology, Media, and CommunicationsOperatorWelcome to TTEC's fourth quarter and full year 2025 earnings conference call. I wou ...

Arcosa (NYSE:ACA) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAntonio Carrillo - President and CEOErin Drabek - VP of Investor RelationsEthan Roberts - Equity Research AssociateGail Peck - CFOGarik Shmois - Managing DirectorIan Zaffino - Managing DirectorConference Call ParticipantsBrent Thielman - Managing Director and Senior Research AnalystJulio Romero - Senior Equity Research AnalystOperatorGood morning, ladies and gentlemen, and welcome to the Arcosa, Inc. fourth quarter and ...

Financial Data and Key Metrics Changes - Net investment income (NII) per share for Q4 2025 was $0.39, while GAAP net loss per share was $0.14, which includes approximately $0.04 of one-time financing-related expenses [6][7] - NAV per share decreased to $14.18, down 3.3% from the previous quarter, primarily due to a few investments from earlier vintages [7] - Total investment income for the December quarter was approximately $78.4 million, a decline of $4.2 million or 5.1% from the prior quarter [20] Business Line Data and Key Metrics Changes - New commitments in the December quarter totaled $141 million across 26 transactions, with a weighted average spread of 497 basis points [12] - The portfolio had a fair value of $3.17 billion, invested in 247 companies across 46 different industries, with 99% of the direct origination portfolio being first lien [13][14] - The weighted average yield at cost of the direct origination portfolio was 10%, down from 10.3% in the previous quarter [14] Market Data and Key Metrics Changes - The weighted average net leverage on new commitments was 4x, and the weighted average interest coverage ratio improved to 2.3x [12][18] - Investments on non-accrual status declined to 2.6% of the portfolio at fair value, down from 3.1% in the prior quarter [16] - PIK income represented 4.8% of total investment income for the December quarter, remaining stable quarter-over-quarter [19] Company Strategy and Development Direction - The company plans to aggressively utilize a new $100 million stock repurchase plan, believing that repurchasing shares at a discount to NAV is more accretive than new investments [10] - The board declared a quarterly dividend of $0.31 per share, reflecting a reassessment of the company's long-term earning power [11] - The company remains focused on first lien positions and cautious usage of PIK, positioning itself well despite market challenges [7][10] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the persistence of market discounts and indicated a commitment to ensuring shareholders receive their true returns [27][28] - The company is optimistic about the repayment of its Merx exposure, which is expected to cushion the dividend and improve capital structure initiatives [38] - Management noted that the current market price does not reflect the intrinsic value of the investment portfolio [10] Other Important Information - The company restored two investments to accrual status during the quarter, including LendingPoint and Compass Health, which was fully repaid [17] - The cost of debt for the quarter declined to 5.95%, down from 6.37% in the prior quarter, due to refinancing activities [23] Q&A Session Summary Question: Future strategies regarding stock buybacks - Management indicated they would consider all options to ensure shareholders receive full value, acknowledging persistent market discounts [26][27] Question: Clarification on the new $100 million repurchase plan - The new repurchase plan is discretionary, with normal trading restrictions applying, and a 10b5-1 plan will be implemented to maximize share purchases during quiet periods [34][35] Question: Sustainability of the new dividend level - Management expressed confidence in the new dividend level of $0.31, citing macroeconomic factors and expected repayments from Merx as supportive of this decision [36][38] Question: Concerns about software exposure and leverage - Management explained their focus on companies with consistent performance and financial covenants, which mitigates risks associated with higher leverage in the software sector [41][42] Question: Common issues among underperforming credits - Management clarified that the underperforming credits are older investments that have been monitored over time, with specific idiosyncratic issues contributing to their current status [50][51]

inTEST (NYSEAM:INTT) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsDuncan Gilmour - CFO and TreasurerNick Grant - President and CEOSanjay Hurry - IR CoordinatorConference Call ParticipantsDick Ryan - Senior Research AnalystMax Michaelis - Equity Research AnalystTed Jackson - Managing Director and Senior Equity Research AnalystOperatorGreetings. Welcome to inTEST Corporation's fourth quarter 2025 financial results conference call. At this time, all participants are in listen-only mo ...

Amneal Pharmaceuticals (NasdaqGS:AMRX) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAnastasios Konidaris - EVP and CFOAnthony DiMeo - Head of Investor RelationsChintu Patel - Co-Founder and Co-CEOChirag Patel - Co-Founder and Co-CEOChris Schott - Managing DirectorJoe Renda - SVP and Chief Commercial OfficerConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystLes Sulewski - AnalystMatt Dellatorre - VP and Equity AnalystOperatorThank you all for ...

Fulgent Genetics (NasdaqGM:FLGT) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAndrew Cooper - Director and Equity ResearchBrandon Perthuis - Chief Commercial OfficerDavid Westenberg - Managing Director and Equity ResearchLauren Sloane - Head of Investor RelationsLu Li - Healthcare Equity Research and DirectorMing Hsieh - Chairman and CEOPaul Kim - CFOOperatorGreetings, welcome to Fulgent Genetics Fourth Quarter 2025 Conference Call and Webcast. At this time, all participants are i ...

Photronics (NasdaqGS:PLAB) Q1 2026 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsEric Rivera - President and CFOFrank Lee - Head of Asia OperationsGeorge Macricostas - Chairman and CEOTed Moreau - VP of Investor RelationsConference Call ParticipantsBen Taxdahl - Equity Research AnalystGowshihan Sriharan - Equity Research AnalystOperatorWelcome to the Photronics' first quarter and fiscal year 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the ...

Arcosa (NYSE:ACA) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAntonio Carrillo - President and CEOErin Drabek - VP of Investor RelationsEthan Roberts - Equity Research AssociateGail M. Peck - CFOGarik Shmois - Managing DirectorIan Zaffino - Managing DirectorConference Call ParticipantsBrent Thielman - Managing Director and Senior Research AnalystJulio Romero - Senior Equity Research AnalystOperatorGood morning, ladies and gentlemen, and welcome to the Arcosa, Inc. fourth quarter ...

Aura Minerals (NasdaqGS:AUGO) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsKleber Cardozo - CFONatasha Utescher - Investor Relations Executive and Treasury ManagerRodrigo Barbosa - President and CEOConference Call ParticipantsEdgard de Souza - Sell-Side Equity Research AnalystEnrique Marquez - Investment Banking AnalystGuilherme Cipis - Equity Research AnalystLawson Winder - Senior Equity Research AnalystMarcelo Arazi - Lead Equity Research AnalystMateus Moreira - Equity Research ...